Veterinary CRO Market by Service Type (Clinical Trials, Toxicology, Market Authorization & Regulatory Support and Others), Application (Dogs, Cats, and Others), End User (Oncology, Infectious Diseases, Neurology and Others): Global Opportunity Analysis and Industry Forecast, 2019 - 2026
- Published Date: 2020-10-18
- Report ID: 3847
- Pages: 181
-
Format:
The global veterinary CRO market was valued at $485.5 million in 2018, and is expected to reach $894.7 million by 2026, registering a CAGR of 7.9% from 2019 to 2026.
Contract research organizations (CROs) are companies that aid in conducting research for a sponsor company. Moreover, veterinary CROs are companies, which are specialized in in-vivo studies that involve companion animals. Sponsor companies seek provision from veterinary CROs to support research and development programs for biopharmaceutical industries. Furthermore, different types of services are provided by veterinary CROs such as clinical trials, toxicology, and market authorization & regulatory support. These services are utilized by veterinary medicine manufacturers to test the safety and efficacy of veterinary drugs, which are used in different indications such as oncology, neurology, and infectious diseases.
The factors that boost the growth of the veterinary CRO market include surge in ownership of companion animals and rise in animal health expenditure. Furthermore, other factors such as increase in prevalence of various diseases among companion animal acts as a major factor that contributes toward the growth of the market. However, lack of standardization in veterinary CROs is a factor that restrains the growth of the market. Conversely, surge in awareness related to animal healthcare across the globe is expected to provide lucrative opportunities in the market during the forecast period.
The veterinary CRO market is segmented into service type, animal type, indication, and region. On the basis of service type, the market is divided into clinical trials, toxicology, market authorization & regulatory support, and others. By animal type, the market is classified into dogs, cats, and others. Depending on indication, it is categorized into oncology, infectious disease, neurology, and others. Region wise, it is analyzed across North America (U.S, Canada, and Mexico) and Europe (Germany, France, Italy, Spain, UK and rest of Europe), Asia-Pacific (Japan, China, Australia, rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
This report entails a detailed quantitative analysis along with the current global veterinary CRO market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
The market size and estimations are based on a comprehensive analysis of key developments in the industry.
A qualitative analysis based on innovative service types facilitates strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Key Market Segments
By Service Type
o Clinical Trials
o Toxicology
o Market Authorization & Regulatory Support
o Others
By Animal Type
o Dogs
o Cats
o Others
By Indication
o Oncology
o Infectious Disease
o Neurology
o Others
By Region
o North America
o U.S.
o Canada
o Mexico
o Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
o Asia-Pacific
o Japan
o China
o Australia
o Rest of Asia-Pacific
o LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest Of LAMEA
List of key players profiled in the report:
Charles River Laboratories, Inc.
Clinvet
KLIFOVET AG
Lhlein & Wolf Vet Research
Oncovet Clinical Research
ONDAX Scientific
Triveritas
Veterinary Research Management (VRM) Ltd
VetPharm, Inc.
VETSPIN SRL
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
AlcheraBio
Likarda
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.1.1. Top Impacting Factors
2.1.2. Top Investment Pockets
2.2. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Porter'S Five Forces Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Thereat of New Entrants
3.2.4. Threat of Substitutes
3.2.5. Intensity of Competitive Rivalry
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Surge In Ownership of Companion Animals
3.3.1.2. Rise In Animal Health Expenditure
3.3.1.3. Increase In Prevalence of Various Diseases Among Companion Animals
3.3.2. Restraint
3.3.2.1. Lack of Standardization In Veterinary Cros
3.3.3. Opportunity
3.3.3.1. Surge In Awareness Related To Animal Healthcare
3.3.4. Impact Analysis
Chapter 4: Veterinary Cro Market, By Service Type
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Clinical Trials
4.2.1. Key Market Trends And Growth Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis By Country
4.3. Toxicology
4.3.1. Key Market Trends And Growth Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis By Country
4.4. Market Authorization And Regulatory Support
4.4.1. Key Market Trends And Growth Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis By Country
4.5. Others
4.5.1. Key Market Trends And Growth Opportunities
4.5.2. Market Size And Forecast, By Region
4.5.3. Market Analysis By Country
Chapter 5: Veterinary Cro Market, By Animal Type
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Dogs
5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis By Country
5.3. Cats
5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis By Country
5.4. Others
5.4.1. Market Size And Forecast, By Region
5.4.2. Market Analysis By Country
Chapter 6: Veterinary Cro Market, By Indication
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Oncology
6.2.1. Market Size And Forecast, By Region
6.2.2. Market Analysis By Country
6.3. Infectious Disease
6.3.1. Market Size And Forecast, By Region
6.3.2. Market Analysis By Country
6.4. Neurology
6.4.1. Market Size And Forecast, By Region
6.4.2. Market Analysis By Country
6.5. Others
6.5.1. Market Size And Forecast, By Region
6.5.2. Market Analysis By Country
Chapter 7: Veterinary Cro Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends And Opportunities
7.2.2. Market Analysis By Country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Market Size And Forecast, By Service Type
7.2.2.1.2. U.S. Market Size And Forecast, By Animal Type
7.2.2.1.3. U.S. Market Size And Forecast, By Indication
7.2.2.2. Canada
7.2.2.2.1. Canada Market Size And Forecast, By Service Type
7.2.2.2.2. Canada Market Size And Forecast, By Animal Type
7.2.2.2.3. Canada Market Size And Forecast, By Indication
7.2.2.3. Mexico
7.2.2.3.1. Mexico Market Size And Forecast, By Service Type
7.2.2.3.2. Mexico Market Size And Forecast, By Animal Type
7.2.2.3.3. Mexico Market Size And Forecast, By Indication
7.2.3. North America Market Size And Forecast, By Service Type
7.2.4. North America Market Size And Forecast, By Animal Type
7.2.5. North America Market Size And Forecast, By Indication
7.3. Europe
7.3.1. Key Market Trends And Opportunities
7.3.2. Market Analysis By Country
7.3.2.1. Germany
7.3.2.1.1. Germany Market Size And Forecast, By Service Type
7.3.2.1.2. Germany Market Size And Forecast, By Animal Type
7.3.2.1.3. Germany Market Size And Forecast, By Indication
7.3.2.2. France
7.3.2.2.1. France Market Size And Forecast, By Service Type
7.3.2.2.2. France Market Size And Forecast, By Animal Type
7.3.2.2.3. France Market Size And Forecast, By Indication
7.3.2.3. Uk
7.3.2.3.1. Uk Market Size And Forecast, By Service Type
7.3.2.3.2. Uk Market Size And Forecast, By Animal Type
7.3.2.3.3. Uk Market Size And Forecast, By Indication
7.3.2.4. Italy
7.3.2.4.1. Italy Market Size And Forecast, By Service Type
7.3.2.4.2. Italy Market Size And Forecast, By Animal Type
7.3.2.4.3. Italy Market Size And Forecast, By Indication
7.3.2.5. Spain
7.3.2.5.1. Spain Market Size And Forecast, By Service Type
7.3.2.5.2. Spain Market Size And Forecast, By Animal Type
7.3.2.5.3. Spain Market Size And Forecast, By Indication
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe Market Size And Forecast, By Service Type
7.3.2.6.2. Rest of Europe Market Size And Forecast, By Animal Type
7.3.2.6.3. Rest of Europe Market Size And Forecast, By Indication
7.3.3. Europe Market Size And Forecast, By Service Type
7.3.4. Europe Market Size And Forecast, By Animal Type
7.3.5. Europe Market Size And Forecast, By Indication
7.4. Asia-Pacific
7.4.1. Key Market Trends And Opportunities
7.4.2. Market Analysis By Country
7.4.2.1. Japan
7.4.2.1.1. Japan Market Size And Forecast, By Service Type
7.4.2.1.2. Japan Market Size And Forecast, By Animal Type
7.4.2.1.3. Japan Market Size And Forecast, By Indication
7.4.2.2. China
7.4.2.2.1. China Market Size And Forecast, By Service Type
7.4.2.2.2. China Market Size And Forecast, By Animal Type
7.4.2.2.3. China Market Size And Forecast, By Indication
7.4.2.3. Australia
7.4.2.3.1. Australia Market Size And Forecast, By Service Type
7.4.2.3.2. Australia Market Size And Forecast, By Animal Type
7.4.2.3.3. Australia Market Size And Forecast, By Indication
7.4.2.4. Rest of Asia-Pacific
7.4.2.4.1. Rest of Asia-Pacific Market Size And Forecast, By Service Type
7.4.2.4.2. Rest of Asia-Pacific Market Size And Forecast, By Animal Type
7.4.2.4.3. Rest of Asia-Pacific Market Size And Forecast, By Indication
7.4.3. Asia-Pacific Market Size And Forecast, By Service Type
7.4.4. Asia-Pacific Market Size And Forecast, By Animal Type
7.4.5. Asia-Pacific Market Size And Forecast, By Indication
7.5. Lamea
7.5.1. Key Market Trends And Opportunities
7.5.2. Market Analysis By Country
7.5.2.1. Brazil
7.5.2.1.1. Brazil Market Size And Forecast, By Service Type
7.5.2.1.2. Brazil Market Size And Forecast, By Animal Type
7.5.2.1.3. Brazil Market Size And Forecast, By Indication
7.5.2.2. South Africa
7.5.2.2.1. South Africa Market Size And Forecast, By Service Type
7.5.2.2.2. South Africa Market Size And Forecast, By Animal Type
7.5.2.2.3. South Africa Market Size And Forecast, By Indication
7.5.2.3. Saudi Arabia
7.5.2.3.1. Saudi Arabia Market Size And Forecast, By Service Type
7.5.2.3.2. Saudi Arabia Market Size And Forecast, By Animal Type
7.5.2.3.3. Saudi Arabia Market Size And Forecast, By Indication
7.5.2.4. Rest of Lamea
7.5.2.4.1. Rest of Lamea Market Size And Forecast, By Service Type
7.5.2.4.2. Rest of Lamea Market Size And Forecast, By Animal Type
7.5.2.4.3. Rest of Lamea Market Size And Forecast, By Indication
7.5.3. Lamea Market Size And Forecast, By Service Type
7.5.4. Lamea Market Size And Forecast, By Animal Type
7.5.5. Lamea Market Size And Forecast, By Indication
Chapter 8: Competitive Landscape
8.1. Introduction
8.1.1. Market Player Positioning, 2018
8.2. Top Winning Strategies And Key Developments
8.3. Competitive Dashboard
8.4. Competitive Heatmap
Chapter 9: Company Profiles
9.1. Charles River Laboratories, Inc.
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Operating Business Segments
9.1.4. Product Portfolio
9.1.5. Business Performance
9.1.6. Key Strategic Moves And Developments
9.2. Clinvet
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Operating Business Segments
9.2.4. Product Portfolio
9.2.5. Key Strategic Moves And Developments
9.3. Klifovet Ag
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Operating Business Segments
9.3.4. Product Portfolio
9.4. Lhlein & Wolf Vet Research
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Operating Business Segments
9.4.4. Product Portfolio
9.4.5. Key Strategic Moves And Developments
9.5. Oncovet Clinical Research
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Operating Business Segments
9.5.4. Product Portfolio
9.6. Ondax Scientific
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Operating Business Segments
9.6.4. Product Portfolio
9.6.5. Key Strategic Moves And Developments
9.7. Triveritas
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Operating Business Segments
9.7.4. Product Portfolio
9.8. Veterinary Research Management (Vrm) Ltd
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Operating Business Segments
9.8.4. Product Portfolio
9.9. Vetpharm, Inc.
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Operating Business Segments
9.9.4. Product Portfolio
9.10. Vetspin Srl
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Operating Business Segments
9.10.4. Product Portfolio
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
